Guiling Wang
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced biosensing and bioanalysis techniques 4
- Ubiquitin and proteasome pathways 3
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 3
- Co-authors
- Feng Li (6 shared papers)Xinze Cai (3 shared papers)Liu Cao (6 shared papers)Maosheng Cheng (2 shared papers)Zhi‐Feng Miao (5 shared papers)Ying Xie (8 shared papers)Jian Wang (1 shared paper)Funan Liu (1 shared paper)
- Journals
- Chinese Chemical Letters (4 papers)Oncotarget (3 papers)Oncogene (2 papers)Biomedicine & Pharmacotherapy (2 papers)Bioactive Materials (2 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Guiling Wang
56 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Molecular Medicine 65
- Biomaterials 151
- Molecular Biology 637
- Cancer Research 123
- Oncology 191
Countries citing papers authored by Guiling Wang
This map shows the geographic impact of Guiling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Wang more than expected).
Fields of papers citing papers by Guiling Wang
This network shows the impact of papers produced by Guiling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Wang. The network helps show where Guiling Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 113 | |
| 2 | 2008 | 107 | |
| 3 | 2008 | 88 | |
| 4 | 2017 | 75 | |
| 5 | 2013 | 56 | |
| 6 | 2013 | 50 | |
| 7 | 2015 | 44 | |
| 8 | 2015 | 41 | |
| 9 | 2022 | 39 | |
| 10 | 2015 | 39 | |
| 11 | 2017 | 33 | |
| 12 | 2010 | 30 | |
| 13 | 2021 | 24 | |
| 14 | 2012 | 23 | |
| 15 | 2019 | 22 | |
| 16 | 2019 | 20 | |
| 17 | 2017 | 20 | |
| 18 | 2022 | 19 | |
| 19 | 2024 | 18 | |
| 20 | 2023 | 18 |
About Guiling Wang
Guiling Wang is a scholar working on Molecular Biology, Immunology, Biomedical Engineering, Oncology and Cell Biology, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Luminescence and Fluorescent Materials (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (3 papers), RNA Research and Splicing (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Molecular Medicine (65 citations), Biomaterials (151 citations), Molecular Biology (637 citations), Cancer Research (123 citations) and Oncology (191 citations). Guiling Wang has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Feng Li, Xinze Cai, Liu Cao, Maosheng Cheng, Zhi‐Feng Miao, Ying Xie, Jian Wang, Funan Liu, Wan-Liang Lü and Huimian Xu. Their work appears in journals such as Chinese Chemical Letters, Oncotarget, Oncogene, Biomedicine & Pharmacotherapy and Bioactive Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.